BPA Call VA25917A0044-VA25917J6996

Roche Diagnostics Corporation was awarded a blanket purchase agreement (BPA) against the General Services Administration (GSA) Federal Supply Schedule 66-III, Critical Analyzers, Laboratory, to provide HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) testing reagents and supplies to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16. The BPA has a potential value of $0.00 and a completion date of April 30, 2023. It was awarded on May...

The Department of the Army Medical Command awarded a $54,720 firm fixed price blanket purchase agreement call contract to Gen-Probe Incorporated on April 18, 2019 for PRD03705APTIMA HIV1 QUANT DX, KIT PAN. Under the contract, Gen-Probe Sales & Service, Inc. will deliver HIV-1 quantification diagnostic kits to the agency's location in Silver Spring, Maryland by April 26, 2019. The contract was awarded without a set-aside designation through an unspecified government-wide acquisition...

This is a Cost-Per-Reportable-Result (CPRR) Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 16 to Abbott Laboratories Inc. for hepatitis and HIV testing instrumentation, reagents, and supplies. The $86,042.61 ceiling value contract has an ultimate completion date of September 30, 2018 and is under the Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III). No set-aside designation was used. This BPA is...

This federal contract award HHSD2002016M90153P was made by the Centers for Disease Control and Prevention (CDC) to Bio Rad Laboratories Inc., a global manufacturer of life science research and clinical diagnostic products. The $95,232.30 Firm Fixed Price contract is for the provision of 480 HIV 1/2 PLUS 0 test kits. This contract does not involve any set-aside designation. Bio Rad Laboratories Inc. is a subsidiary of the larger Bio-Rad Laboratories, Inc. corporation, which serves as a prime...

This federal contract award is for the APTIMA HIV-1, PRD-03565 product from Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract, awarded by the Defense Health Agency, is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price type and a ceiling value of $112,672.00. The contract does not have a set-aside designation and is set to be completed by July 7, 2023. Gen-Probe Incorporated has held several federal...

This federal contract award to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings, is for the provision of medical laboratory testing services to detect the antigens and antibodies of Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antibody (HBsAb), Hepatitis B Surface Antigen (HBsAg), and Hepatitis C Virus (anti-HCV). The award, issued by the U.S. Department of Defense's Readiness Center, has a ceiling value of $958,699.10 and a period of...

This contract was awarded by the Department of the Army Medical Command to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $124,693.14 firm fixed price contract is for HIV-1 TEST V2.0 PN#5212308190, with a completion date of March 6, 2020. The contract was not set aside for any particular business type. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and...

This is a $4,914,300.00 firm-fixed-price delivery order contract awarded by the Defense Health Agency (DHA) to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings. The contract is for the provision of medical laboratory testing services to detect antigens and antibodies of Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antibody (HBsAb), Hepatitis B Surface Antigen (HBsAg), and Hepatitis C Virus (anti-HCV) for the U.S. military. The contract...

This federal contract award, valued at $63,189.00, was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the parent company Bio-Rad Laboratories, Inc. The award is for the provision of HIV diagnostic testing products, including GS HIV-1/HIV-2 PLUS O EIA, GEENIUS HIV 1/2 Supplemental Assay, GEENIUS HIV 1/2 Controls, and GS HIV-1 Western Blot. These products support the President's Emergency...

Bio-Rad Laboratories, Inc. Life Science Group Division was awarded a $99,863.40 firm fixed price purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention to provide tests kits for the detection of HIV-2 antibodies. The place of performance is Atlanta, Georgia and all work must be completed by September 30, 2022. No set-aside designation was used for this contract. Bio-Rad Laboratories, Inc. is the prime contractor and parent company to the Life...